Usuku Lobuhlungu Besifuba SaseShayina: Ukuvala Igebe Lemizuzu Eyi-120

Njalo ngoNovemba 20 kugujwa uSuku Lobuhlungu Besifuba saseShayina. Usuku "1120" luphethe imiyalezo emibili: shayela u-120 ngokushesha lapho ubuhlungu besifuba bufika, bese uzama ukuvula umthambo ovalekile zingakapheli imizuzu eyi-120. Leli "fasitela legolide" liphindaphindwa ngesizathu esisodwa: i-myocardial necrosis ayinakuguqulwa. Umzuzu ngamunye wokulibaziseka usho ukuthi imisipha yenhliziyo eminingi ilahleka unomphela.

Kodwa-ke igebe phakathi komqondo ofanele kanye neqiniso lisalokhu libanzi. Ngokusho kwe-Umbiko Wezempilo Nezifo Zenhliziyo waseShayina ka-2024ekhishwe yiNational Center for Cardiovascular Diseases, iShayina inamacala amasha angaphezu kwezigidi ezintathu e-myocardial infarction (MI) njalo ngonyaka, kanye nesibalo sabantu abangu-62 kwabangu-100,000. Iziguli ezingaphansi kweminyaka engu-40 manje zingu-15% wamacala. Ukufa kwabantu abangaphandle kwesibhedlela ngenxa ye-MI ebukhali kuphezulu njengo-30.2%, futhi kufinyelela ku-38.7% ezindaweni zasemakhaya. Ngokuphambene nalokho, ukufa kwabantu esibhedlela ngaphakathi kwenethiwekhi yezikhungo zobuhlungu besifuba kwehle ngaphansi kuka-3% okokuqala ngo-2025, kwafinyelela cishe ku-2.9%. Lo mehluko obukhali "wangaphandle kwesibhedlela uma uqhathaniswa nowasesibhedlela" usikisela ukuthi okuvame ukunquma ukusinda akugcini nje ngokuba namandla okwelashwa esibhedlela, kodwa nesikhathi esilahlekile ngaphambi kokuba isiguli sifinyelele endaweni yokunakekelwa ephumelelayo. Inkinga eyodwa enganakwa kalula phakathi kokuqala kwezimpawu nokungenelela okuqinisekisiwe isikhathi sokushintsha kokuhlolwa kwe-biomarker yenhliziyo.

I-troponin yenhliziyoyi-biomarker eyinhloko yokuxilonga i-acute myocardial infarction. Isiqondiso se-ACC/AHA sika-2025 se-acute coronary syndromes sincoma izindlela zokuxilonga ezisheshayo ze-cardiac troponin (hs-cTn) 0/1-hora noma 0/2-hora ukuze kuvunyelwe ukumiswa noma ukususwa kwangaphambilini emnyangweni wezimo eziphuthumayo. Kodwa-ke, ukuhlolwa kwelabhorethri ephakathi kuvame ukuthatha amahora amaningi, okunzima ukukuvumelanisa nesidingo "semizuzu eyi-120". Ukuhlolwa kwendawo yokunakekelwa (i-POCT) ye-hs-cTn kushintsha lesi sithombe. Ukubuyekezwa okuhlelekile kubonise ukuthi ukuhlolwa kwe-POCT hs-cTn akunawo umehluko omkhulu ekuhlolweni kwelabhorethri ngokunemba kokuxilonga kwe-acute MI, ngokuzwela kanye nenani elibi lokubikezela kokubili kudlula u-99%, kuyilapho kunciphisa kakhulu isikhathi sokubika futhi kusheshiswe izinqumo zezokwelapha. Lokhu kusho ukuthi ukuhambisa ukuhlolwa okuthembekile eduze komnyango wezimo eziphuthumayo, isikhungo sezinhlungu zesifuba, ngisho nezilungiselelo zokuxhumana kokuqala kokunakekelwa okuyinhloko kuyindlela ewusizo yokucindezela "ukubambezeleka kokwelashwa."

Kulesi siqondiso, iphothifoliyo yethu yokuhlola inhliziyo nemithambo yegazi inikeza izinsika ezimbili ezihambisanayo.I-WIZ-A101Isihlaziyi se-immunoassay esiphathwayo sibekwe “njengelebhu yesundu”: sincane, sisebenza ngebhethri, futhi sinamandla okukhipha amandla angu-150 T/H. Singasebenzisa i-cardiac troponin I kanye namanye amakhadi e-cardiovascular marker reagent, okwenza sifanelekele ukuhlolwa okuphuthumayo eceleni kombhede, izikhungo zobuhlungu besifuba, izikhungo zokunakekelwa okuyisisekelo, kanye nezilungiselelo zangaphambi kwesibhedlela—siguqula “amasampula alinde izinsimbi” abe “izinsimbi ezilinde izibonelo.”I-WIZ-A203 I-analyzer ye-immunoassay yeziteshi eziningi ibhekana nezidingo zokuhlolwa kweqembu ezikhungweni zokunakekelwa okuyisisekelo kanye nasezilabhorethri ezincane kuya kweziphakathi: inikeza ukuhlolwa okuhambisanayo kweziteshi eziyi-10, ukushintshana okuyisihluthulelo esisodwa phakathi kwezindlela zegolide le-colloidal kanye ne-fluorescence, ukunemba okuphezulu kanye ne-CV ephansi kwimodi ye-fluorescence, imodyuli yokulawula izinga lokushisa eyakhelwe ngaphakathi yemiphumela ezinzile ezindaweni ezahlukene, kanye nomphumela ofinyelela ku-70 T/H. Ndawonye, ​​​​lezi zinsimbi ezimbili zimboza izimo zokuhlolwa kwezimpawu zenhliziyo kusukela "ku-triage esheshayo yesampula eyodwa" kuya "kukuhlolwa kweqembu le-multi-sample," ukuze ukuhlolwa kwe-hs-cTn kungasagcini emalabhorethri amakhulu ezibhedlela ezinkulu.

ami_infographic_1000x500

Incazelo yoSuku Lobuhlungu Besifuba saseShayina ayikona nje ukuphakamisa ulwazi lomphakathi "ngama-120 amabili," kodwa futhi nokucindezela zonke izinyathelo ezingcono ukuze kufinyezwe ngempela leyo mizuzu engu-120. Kumkhiqizi wezinto zokwelapha kanye namathuluzi, ukunikeza ukuhlolwa kwe-biomarker yenhliziyo okunembile, okusheshayo, nokufinyeleleka kalula ezindaweni eziseduze neziguli kuyindlela ewusizo kakhulu "yesikhathi yimisipha." Uma umuntui-troponinUma ubika izinguquko kusukela “ekulindeni imiphumela” kuya “emiphumeleni etholakalayo ngokushesha,” ifasitela lokwelashwa eliyigolide liba yinto engabanjwa ngempela.


Isikhathi sokuthunyelwe: Novemba-16-2026